Abstract: Disclosed are a super-resolution imaging system (1, 41, 51), a super-resolution imaging method, a biological sample identification system (4, 61) and method, a nucleic acid sequencing imaging system (5) and method, and a nucleic acid identification system (6) and method. The super-resolution imaging system (1, 41, 51) includes an illumination system (A) and an imaging system (B). The illumination system (A) outputs excitation light to irradiate a biological sample to generate excited light, and the imaging system (B) collects and records the excited light to generate an excited light image. The illumination system (A) includes an excitation light source (10, 10a) and a structured light generation and modulation device (11, 11a). The excitation light source (10, 10a) outputs the excitation light, and the structured light generation and modulation device (11, 11a) modulates the excitation light into structured light to irradiate the biological sample to generate the excited light.

Abstract: A hybrid solid-state electrolyte layer for use in an electrochemical cell is provided. The hybrid solid-state electrolyte layer includes a polymeric material, a ceramic material, and an interfacial material adhering the polymeric material and the ceramic material. The interfacial material includes a branched copolymer that includes dopamine and a second monomer. The second monomer forms a polymeric moiety in the copolymer that is the same or similar to the polymeric material. In certain variations, the polymeric material defines a polymeric layer, the ceramic material defines a ceramic layer, and the interfacial material defines an interfacial layer that is disposed between the polymeric layer and the ceramic layer. In other variations, the polymeric material defines a polymeric matrix, the ceramic material defines a plurality of ceramic particles dispersed in the polymeric matrix, and the plurality of ceramic particles are coated with the interfacial material.

Abstract: An LED tube lamp includes a first and second members and a connection member. Each of the first and second members includes lighting part and an end part. Each lighting part includes LED light strip. The connection member includes electrical connection portions and joining portions for the first and second members. The connection member connects the first member with the second member by the joining portions and the electrical connection portions and makes the first member substantially coaxial to the second member.

Abstract: Disclosed are a method for activating an audio device, a terminal device and a computer-readable storage medium. The method may include: acquiring an attribute of an audio application; acquiring an audio device identification (ID) mapped to the attribute from a preset audio device switching routing table according to the attribute, wherein the audio device ID mapped to the attribute may include: an audio device ID of an audio device codec corresponding to the attribute; and activating the audio device corresponding to the audio device ID.

Abstract: A node synchronization method, includes: receiving a synchronization message by a first synchronization node in a network; determining whether to update a first local time of the first synchronization node according to the synchronization message by the first synchronization node; updating the first local time according to a synchronization time of the synchronization message by the first synchronization node when determining to update the first local time; and updating the synchronization time of the received synchronization message with the current first local time and forwarding the updated synchronization message by the first synchronization node.

Abstract: The present disclosure relates to genetically modified B cells, including memory cells, differentiated to plasmablasts or plasma cells useful for long term in vivo expression of a transgene, such as a specific antibody or other protein therapeutic. Also disclosed are methods of producing the cells and methods of treatment.

Abstract: The present invention discloses a bactericidal composition for controlling gummy stem blight of melons. The bactericidal composition includes an active ingredient composed of Pydiflumetofen and Thifluzamide. An appropriate amount of agricultural bactericide adjuvant is added into the bactericidal composition to be prepared into a common agricultural bactericide dosage form. The two components in the present invention have no cross resistance. After combined according to a certain ratio, the two agents have an obvious synergistic effect, and have a more excellent effect of controlling fungal diseases of crops. Due to the combined use, the dose may be decreased; drug resistance of pathogenic bacteria to a single agent may be delayed; ecological damage and environmental pollution are effectively decreased; and crop yield and quality can be increased. The composition widens a disease resistance spectrum.

Abstract: The present disclosure relates to the in vitro differentiation of memory B cells to plasmablasts or plasma cells and genetic modification of these cells to express a protein of interest, such as a specific antibody or other protein therapeutic.

Abstract: The present disclosure relates to the in vitro differentiation of memory B cells to plasmablasts or plasma cells and genetic modification of these cells to express a protein of interest, such as a specific antibody or other protein therapeutic.

Abstract: Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.

Abstract: The present application discloses a method for planting and processing high-yield forage in high altitude area, and belongs to the technical field of feed preparation in a high altitude area. The planting method of the present application comprises the steps of: intercropping maize and soybeans at an altitude of more than 3000 m, and the maize varieties include Demeiya No. 1 and Demeiya No. 3, the soybean varieties include Zhongdou No. 39 and Huachun No. 6. The planting method of the present application can realize the successful planting of maize and soybeans in a high altitude area (>3000 m), and can greatly improve the biological yield.

Abstract: The present disclosure relates to the in vitro differentiation of memory B cells to plasmablasts or plasma cells and genetic modification of these cells to express a protein of interest, such as a specific antibody or other protein therapeutic.

Abstract: Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.

Abstract: The present disclosure relates to the in vitro differentiation of memory B cells to plasmablasts or plasma cells and genetic modification of these cells to express a protein of interest, such as a specific antibody or other protein therapeutic.

Abstract: Embodiments of the present application provide a network performance monitoring method and apparatus. The apparatus records a time (e.g. a first time) at which a first network device sends a first packet to a second network device, records a time (e.g. a second time) at which the first network device receives a response packet of the first packet, and determines a round-trip delay between the first and second network devices according to the first and second times; within a preset time, the apparatus collects statistics about a quantity (e.g. a first count) of first packets that are sent by the first network device to the second network device, and collects statistics about a quantity (e.g. a second count) of retransmitted packets in the first packets, and determines a packet loss rate from the first network device to the second network device according to the first and second counts.

Abstract: The present disclosure relates to genetically modified B cells, including memory cells, differentiated to plasmablasts or plasma cells useful for long tem in vivo expression of a transgene, such as a specific antibody or other protein therapeutic. Also disclosed are methods of producing the cells and methods of treatment.

Abstract: The present disclosure relates to the in vitro differentiation of memory B cells to plasmablasts or plasma cells and genetic modification of these cells to express a protein of interest, such as a specific antibody or other protein therapeutic.

Abstract: Embodiments of the present application provide a network performance monitoring method and apparatus. The apparatus records a time (e.g. a first time) at which a first network device sends a first packet to a second network device, records a time (e.g. a second time) at which the first network device receives a response packet of the first packet, and determines a round-trip delay between the first and second network devices according to the first and second times; within a preset time, the apparatus collects statistics about a quantity (e.g. a first count) of first packets that are sent by the first network device to the second network device, and collects statistics about a quantity (e.g. a second count) of retransmitted packets in the first packets, and determines a packet loss rate from the first network device to the second network device according to the first and second counts.